Skip to main content
TMDX logo
TMDX
(NASDAQ)
TransMedics Group, Inc.
$100.70-- (--)
Loading... - Market loading

TransMedics Group (TMDX) Stock Price & Financial Analysis

TransMedics Group Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$96.01 - $101.73
52-Week High$156.00
52-Week Low$62.23
Open$97.31
Volume551.08K
Average Volume (3M)551.08K
Market Cap4.08B
Shares Outstanding40.54M
P/E Ratio (TTM)21.39
Forward P/E10.80
Price to Sales (P/S)6.72
Price to Book (P/B)8.60
EV/EBITDA27.29
Revenue (TTM)605.49M
Net Income (TTM)190.29M
Free Cash Flow (TTM)133.59M
EPS (TTM)$4.65
Profit Margin31.43%
Operating Margin17.93%
Return on Equity (ROE)40.22%
Debt to Equity0.99
50-Day MA$128.30
200-Day MA$124.45
52-Week Change47.06%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About TransMedics Group

What is the current stock price for TMDX?

As of the latest trading session, TMDX stock trades at $100.69. The 52-week range is $62.23–$156.00, with a day range of $96.01–$101.73.

What is the P/E ratio for TMDX?

TransMedics Group's trailing P/E ratio is 21.4, meaning investors pay $21.4 for every $1 of annual earnings. The forward P/E is 10.8, reflecting analyst expectations for future earnings. TransMedics Group operates in the Healthcare sector.

Does TMDX pay dividends?

TransMedics Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TMDX?

Based on 6 analysts, the consensus for TMDX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TMDX?

TransMedics Group's market capitalization is $4.08B, classifying it as a mid-cap company. TransMedics Group operates in the Healthcare sector within the Medical Devices industry.